Individualized Therapy Based of Tumoral mRNA Levels of ERCC1, RRM1 and BRCA1 in Advanced Non-Small-Cell Lung Cancer
Status:
Terminated
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
This is a prospective pilot phase II trial, in patients with wet stage IIIb and IV NSCLC
using chemotherapy regimens which will be defined according to the pharmacogenomic profile
(tumoral expression of ERCC1, BRCA1 and RRM1) of the tumor cells.